Lemaitre Vascular (LMAT) Price to Earnings (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Price to Earnings for 17 consecutive years, with 128.69 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Earnings fell 5.68% year-over-year to 128.69 in Q2 2026; TTM through Jun 2026 was 33.41, a 17.07% decrease from a year earlier, with the FY2025 full-year figure at 31.99, down 32.89% from the prior year.
• Price to Earnings was 128.69 for Q2 2026 at Lemaitre Vascular, down from 159.08 in the prior quarter.
• Over five years, Price to Earnings peaked at 284.61 in Q2 2022 and troughed at 114.34 in Q3 2025.
• A 5-year average of 169.29 and a median of 165.31 in 2022 frame the typical range for Price to Earnings.
• Across the five-year window, Price to Earnings jumped 78.7% in 2022 and plunged 39.0% in 2025, its largest moves.
• Over 5 years, Price to Earnings stood at 186.76 in 2022, then dropped by 19.8% to 149.78 in 2023, then rose by 29.25% to 193.58 in 2024, then tumbled by 38.77% to 118.53 in 2025, then rose by 8.57% to 128.69 in 2026.
• The last three Price to Earnings figures came in at 128.69 (Q2 2026), 159.08 (Q1 2026), and 118.53 (Q4 2025), per Business Quant data.